Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-04-13
1999-07-13
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514270, 514282, 514289, 514722, 514731, 514812, A61K 3155, A61K 31515, A61K 3144, A61K 3108, A61K 3105
Patent
active
059227052
ABSTRACT:
Methods for rapid detoxification of patients addicted to opioid narcotics are provided. The methods include administering nalmefene to induce acute withdrawal, and administering dextromethorphan with nalmefene or other opioid antagonists to reduce the patient's subjective feelings of residual withdrawal symptoms following detoxification. In one method of rapid detoxification, unconsciousness is induced by anesthetizing the patient with desflurane.
REFERENCES:
patent: 3896226 (1975-07-01), Fishman
patent: 4535157 (1985-08-01), Meltzer et al.
patent: 4987136 (1991-01-01), Krook et al.
patent: 5272149 (1993-12-01), Stalling
patent: 5783583 (1998-07-01), Simon
patent: 5789411 (1998-08-01), Goobermann et al.
Partridge et al., "Pulmonary Edema Following Low-dose Naloxone Administration". Anesthesiology. vol. 65, No. 6. pp. 709-710. 1986.
Taff, "Pulmonary Edema Following Naloxone Administration in a Patient Without Heart Disease", Anesthesiology. 59. 576-77. 1983.
San et al, "High Risk of Ultrashort Noinvasive Opiate Detoxification". Am. J. Psychiatry 152. p. 956. Jun. 1995.
Brewer. C., Ultra-rapid, antagonist-precipitated opiate detoxification under general anesthesia or sedation. Addiction Biology 2/3, pp. 291-302, 1997.
Gerra et al., "Clonidine and Opiate Receptor Antagonists in the Threatment of Herion Addiction". Journal of Substance Abuse Treatment, vol. 12, No. 1. pp. 35-41. 1995.
Loimer et al., "Continuous Naloxone Administration Suppresses Opiate Withdrawel Symptoms In Huamn Opiate Addicts During Detoxification Treatment". 1989 pp. 81-86.
Text--Opioid Peptides in Substance Abuse by Jozsef I. Szekely. CRC Press, Inc., p. 160 (1994).
Article--Spanagel et al.--"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway" Proc. Natl. Acad. Sci. USA vol. 89. p. 2046. Mar. 1992.
Article--Pan et al. "Cellular mechanism for anti-analgesic action of agonists of the k-opioid receptor" Nature vol. 389/25 Sep., pp. 382-385.
Article--Kreeks et al. "Orally Administered opioid antagonists reverse mu and kappa opioid agonists delay of gastrointestinal transit in the guinea pig" Life Sciences, vol. 56. No. 14. pp. 1187-1192. 1995.
Article--Arts et al. "Inhibition of the Antianalgesic Action of Dynorphin A in Mice by Cholera Toxin" Pharacology Biochemistry and Behavior, vol. 46. pp. 623-629, 1993.
Article--Bakashi et al. "Dynorphin A-(l-17) Induces Alterations in Free Fatty Acids, Excitatory Amino Acids, and Motor Function Through An Opiate-Receptor-Mediated Mechanism" The Journal of Neuroscience, Dec. 1990. 10(12): 3793-3800.
Article--Behrmann et al. "A Comparison of YM-14673. U-50488H, and Nalmefene after Spinal Cord Injury in the Rat" Experimental Neurology 119. 258-267 (1993).
Article--Ohnishi et al. "Aquaretic Effect of the Stable Dynorphin-A analog E2078 in the Human" The Journal of Pharmacology and Experimental Therapeutics vol. 270. No. 1. Mar. 19, 1994. -D-LCU.sup.8! --Dynorphin-A-(1-8)Ethylamide, a Stable Dynorphin Analog. Produces Diuresis by Kappa-Opiate Receptor Activation in the Rat" The Journal of Pharmacology and Experimental Therapeutics vol. 262. No. 3. 1992.
Article--Wang et al. "Contribution of Alpha-2 adrenoceptors to Kappa Opioid Agonist-Induced Water Diuresis in the Rat" The Journal of Pharmacology and Experimental Therapeutics vol. 270. 1994.
Article--O'Connor et al. Rapid and Ultrarapid Opioid Detoxification Techniques JAMA. Jan. 21, 1998--vol. 279. No. 3.
CA 112:229588, Koyuncuoglu et al., 1990.
CA 127:288090, Juvin et al., 1997.
Intensive Narcotic Detoxification Centers of America, LLC
Jordan Kimberly
LandOfFree
Rapid narcotic detoxification does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapid narcotic detoxification, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid narcotic detoxification will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2275881